| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/21/2013 | CN103254176A Salt of trachycladindole A derivative |
| 08/21/2013 | CN103254143A 4-[4-(2-diethylamino acetamido)phenylamino]-6-(substituted methoxyl)formylamino quinazoline compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254142A 4-[4-(2-subtituted amino acetylamino)phenylamino] quinazoline derivative as well as preparation method and application thereof |
| 08/21/2013 | CN103254141A 4-[4-(2-dipropylamino acetamido) phenylamino]-6-substituted quinazoline compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254133A Preparation method of diarylpyrazolylaniline compounds, and application of compounds in colorectal cancer treatment |
| 08/21/2013 | CN103254130A Acridine derivative and preparation method and application thereof |
| 08/21/2013 | CN103254126A Deuterated omega-diphenyl carbamide as well as derivative and pharmaceutical composition including compounds |
| 08/21/2013 | CN103254124A N-[4-chloro-3-(pyridinyl-2-radical)phenyl]-2-chloro-4(methylsulfonyl)-benzamide derivative and application thereof |
| 08/21/2013 | CN103254120A Spiro-azasugar quaternary ammonium salt compound, and preparation method and application thereof |
| 08/21/2013 | CN103254079A Compounds for treating cancer pains |
| 08/21/2013 | CN103254078A Cancer pain drug |
| 08/21/2013 | CN103254077A Pain disease therapeutic agent |
| 08/21/2013 | CN103254057A Compounds and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation |
| 08/21/2013 | CN103254055A Compound with anticancer activity and preparation method thereof |
| 08/21/2013 | CN103254054A Compound with cancer prevention effect and preparation method thereof |
| 08/21/2013 | CN103251963A Mixture for curing liver cancer |
| 08/21/2013 | CN103251956A Matrine-montmorillonite nano composite and preparation method thereof |
| 08/21/2013 | CN103251955A High-molecular targeted drug carrier used for bladder tumor perfusion treatment, and preparation method thereof |
| 08/21/2013 | CN103251952A Genetic products differentially expressed in tumors and use thereof |
| 08/21/2013 | CN103251949A Nanometer composite material having gold/tetra-sulfide hepta-copper core-shell structure and preparation method thereof |
| 08/21/2013 | CN103251946A Extending time to disease progression or survival in cancer patients using a her dimerization inhibitor |
| 08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 08/21/2013 | CN103251944A Preparation method of ursolic acid as immunologic adjuvant vaccine and use |
| 08/21/2013 | CN103251942A Folic-adenovirus tumor targeting compound and preparation method thereof |
| 08/21/2013 | CN103251929A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 08/21/2013 | CN103251892A Medicament for treating leukaemia and preparation method thereof |
| 08/21/2013 | CN103251883A Antitumor pharmaceutical composition and preparation method thereof |
| 08/21/2013 | CN103251882A Pharmaceutical composition for treating tumor |
| 08/21/2013 | CN103251880A Pharmaceutical composition for treating tumor and preparation method thereof |
| 08/21/2013 | CN103251876A Traditional Chinese medicine composition used for treating chronic liver diseases |
| 08/21/2013 | CN103251869A Traditional Chinese medicinal psoralen-containing composition for treating stomach cancer and preparation method and application thereof |
| 08/21/2013 | CN103251848A Pharmaceutical composition for preventing and treating gastric cancer and precursor lesion of gastric cancer |
| 08/21/2013 | CN103251771A Traditional chinese medicine composition |
| 08/21/2013 | CN103251745A Traditional Chinese medicine composition for inhibiting hysteromyoma |
| 08/21/2013 | CN103251711A Medicine formula for effectively treating primary lung cancer |
| 08/21/2013 | CN103251706A Traditional chinese medicine composition |
| 08/21/2013 | CN103251705A Edible and medicinal dual-use Chinese herbal medicine composition for treating intestinal tract disease and preparation method and application thereof |
| 08/21/2013 | CN103251660A Traditional chinese medicine composition |
| 08/21/2013 | CN103251658A Antrodia camphorate extraction concentrate and preparation method thereof |
| 08/21/2013 | CN103251650A Application of roe milk in preparation of medicine used for preventing and treating gastric cancer and precancerous lesion |
| 08/21/2013 | CN103251644A Application of Polyflavanostilbene A in preparing medicine for treating liver cancer |
| 08/21/2013 | CN103251643A Application of Polyflavanostilbene A in preparing anti-lung cancer metastasis medicine |
| 08/21/2013 | CN103251642A Application of Polyflavanostilbene A in preparing medicine for treating bile duct cancer |
| 08/21/2013 | CN103251641A Application of Polyflavanostilbene A in preparing medicine for treating skin cancer |
| 08/21/2013 | CN103251640A Application of Polyflavanostilbene A in preparing medicine for treating nasopharyngeal cancer |
| 08/21/2013 | CN103251638A Application of Polyflavanostilbene A in preparing medicine for treating pancreatic cancer |
| 08/21/2013 | CN103251633A Application of phenazopyridine in preparing anti-angiogenesis medicine |
| 08/21/2013 | CN103251624A Application of Aspeverin in preparation of medicines for treating ovarian cancer |
| 08/21/2013 | CN103251617A Application of Aspeverin in preparation of medicines for treating urinary bladder cancer |
| 08/21/2013 | CN103251615A Application of Aspeverin in preparation of medicines for treating laryngeal cancer |
| 08/21/2013 | CN103251613A Application of Aspeverin in preparation of medicines for treating ileocecum cancer |
| 08/21/2013 | CN103251609A Application of Aspeverin in preparation of medicines for treating tongue cancer |
| 08/21/2013 | CN103251605A Application of Myriberine A in preparing medicine for treating breast cancer |
| 08/21/2013 | CN103251604A Application of Myriberine A in preparing medicine for treating renal cancer |
| 08/21/2013 | CN103251601A Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 08/21/2013 | CN103251600A Antitumor application of 2-amino-4-(3'-cyano-4'-pyrrolidyl)phenylpyrimidine compound |
| 08/21/2013 | CN103251599A Pharmaceutical preparation for rapidly releasing citric acid benzene ring tinib and preparation method thereof |
| 08/21/2013 | CN103251596A 7-ethyl-10-hydroxycamptothecin amphiphilic polymer prodrug as well as preparation method and nano-particles thereof |
| 08/21/2013 | CN103251595A Technology for preparing folic acid-glucan-camptothecin composite nanoparticles through supercritical CO2 anti-solvent method |
| 08/21/2013 | CN103251589A SNS-595 and methods of using same |
| 08/21/2013 | CN103251588A Application of phenytoin sodium in preparing anti-angiogenesis medicine |
| 08/21/2013 | CN103251586A Anticancer composition based on anti-angiogenesis medicine |
| 08/21/2013 | CN103251585A Effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A |
| 08/21/2013 | CN103251581A Application of ampelopsin in mutation resistance composition preparation |
| 08/21/2013 | CN103251573A Protein micro/nano sphere carrying antitumor chemotherapeutic medicine and preparation method of protein micro/nano sphere |
| 08/21/2013 | CN103251569A Capecitabine tablet composition and preparation method thereof |
| 08/21/2013 | CN103251567A Agomelatine troche and preparation method thereof |
| 08/21/2013 | CN103251562A Method for improving stability and shelf-life of liposome complexes |
| 08/21/2013 | CN103251561A Double-sensitive disintegrating nano-sized vesica medicine carrier preparation and preparation method thereof |
| 08/21/2013 | CN103251559A Combretastatin A-4 atomization agent and preparation method thereof |
| 08/21/2013 | CN103251558A Preparation of high drug loading multifunction nanometer drug with combination treatment effect |
| 08/21/2013 | CN103251555A Preparation method of high drug loading rod-shaped nanometer drug for cancer treatment |
| 08/21/2013 | CN102772763B Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition |
| 08/21/2013 | CN102772361B Medicament composition with docetaxel |
| 08/21/2013 | CN102755651B Anti-skin squamous cell carcinoma medicament antagomir-365-2 |
| 08/21/2013 | CN102716095B Paclitaxel vesicle type phospholipid gel injection |
| 08/21/2013 | CN102716085B Topotecan hydrochloride liposome injection |
| 08/21/2013 | CN102688199B 地西他滨冻干制剂及其制备方法 Decitabine lyophilized formulation and preparation method |
| 08/21/2013 | CN102652736B Method for preparing soybean isoflavone sustained-release microspheres |
| 08/21/2013 | CN102603887B IL-24 (interleukin-24) polypeptide with tumor resistance and application thereof |
| 08/21/2013 | CN102600279B Traditional Chinese medicine for treating cancer |
| 08/21/2013 | CN102579832B Traditional Chinese medicine for treating tumor |
| 08/21/2013 | CN102579372B Gemcitabine hydrochloride lyophilized composition and preparation method thereof |
| 08/21/2013 | CN102552813B Medicament for treating cancer |
| 08/21/2013 | CN102526666B Ginger-long pepper composition of for reducing vomit caused by cancer chemotherapy and enhancing chemotherapy effect and preparation method thereof |
| 08/21/2013 | CN102526129B Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder |
| 08/21/2013 | CN102499986B Macromolecule-cis-platinum compound, preparation method and application thereof |
| 08/21/2013 | CN102488677B Application of thelephora ganbajun in preparation of antitumor drugs |
| 08/21/2013 | CN102423316B Paclitaxel compound preparation and preparation method thereof |
| 08/21/2013 | CN102391279B Methyl 3,4-seco-4-hydroxy-3-cimigenolate, medicinal composition containing same and preparation method and application thereof |
| 08/21/2013 | CN102362929B Chinese medicinal composition and extract for treating cancer ischemia, and preparation method and formulation of Chinese medicinal extract |
| 08/21/2013 | CN102321012B Acenaphthene heterocyclic compounds and application thereof |
| 08/21/2013 | CN102319310B Chinese herbal medicine with anti-cancer effect |
| 08/21/2013 | CN102311434B Evodiamine compounds, preparation method thereof and application thereof |
| 08/21/2013 | CN102309474B Application of S-propargyl-cysteine in preparation of medicament for treating digestive system tumors |
| 08/21/2013 | CN102293920B Medicine composition for treating primary liver cancer and preparation method thereof |
| 08/21/2013 | CN102268004B Chlorophyllin salt compound and preparation method thereof |
| 08/21/2013 | CN102260320B Compound with antitumor activity and preparation method thereof |
| 08/21/2013 | CN102260225B Phenylpiperazine derivatives for inhibiting tumor metastasis and tumor angiogenesis |
| 08/21/2013 | CN102232960B Epigallocatechin gallate (ECG) and daunorubicin (DNR) composition and use thereof |